Our research indicated that the MWA therapy reprogrammed the tumor microenvironment and suppressed the growth of abscopal tumors by the improvement of systemic antitumor immunity in CT26-bearing mice (Figure 6). The gene discussed is DDX53; the disease is neoplasm.